Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.

Kai En ChanTiffany Jia Ling KohAnsel Shao Pin TangJingxuan QuekJie Ning YongPhoebe TayDarren Jun Hao TanWen Hui LimSnow Yunni LinDaniel HuangMark ChanChin Meng KhooNicholas W S ChewApichat KaewdechNaichaya ChamroonkulYock Young DanMazen NoureddinMark Dhinesh MuthiahMohammed EslamCheng-Han Ng

Published in: The Journal of clinical endocrinology and metabolism (2022)

This meta-analysis supports previous studies in reporting MAFLD to affect more than a third of the global population. While exploration of the pathogenic basis of fatty liver disease without metabolic dysregulation is required, the emphasis on management of concomitant metabolic disease in MAFLD can improve multidisciplinary efforts in managing the complex disease.

Keyphrases

systematic review
meta analyses
case control
risk factors
quality improvement
emergency department
fatty acid
adverse drug